Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Arginine + leucine is a combination of two amino acids, L-arginine and L-leucine, commonly used as a dietary supplement. Both are involved in protein synthesis and metabolic regulation. Arginine is a semi-essential amino acid that serves as a precursor for nitric oxide, which acts as a vasodilator to improve blood flow and has roles in hormone secretion and immune function[3][6][7]. Leucine is an essential branched-chain amino acid (BCAA) critical for muscle protein synthesis, energy regulation, growth hormone production, wound healing, and the prevention of muscle breakdown after trauma or severe stress[5]. When combined as supplements—primarily studied in animal models such as pigs—arginine plus leucine has been shown to decrease body fat weight, alter gut microbiota composition (increasing beneficial short-chain fatty acids), modulate lipid metabolism gene expression in muscle and adipose tissue, improve meat quality traits (in animals), and potentially influence insulin release[1][2][8]. The combination may have potential applications for obesity management or metabolic health; however, most evidence comes from animal studies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on arginine + leucine.